Search results for:
linaGLIPtin-metFORMIN
linaGLIPtin-metFORMIN
| Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
| Jentadueto XR |
TABLET, EXTENDED RELEASE, ORAL |
2.5 mg/1000 mg, 5 mg/1000 mg |
|
|
|
|
| Jentadueto |
TABLET, ORAL |
2.5 mg-500 mg, 2.5 mg-850 mg, 2.5 mg-1,000 mg |
|
|
|
|
Last updated: Dec. 21, 2017
ORDERED FORMULATION
THERAPEUTIC INTERCHANGE
linaGLIPtin-metFORMIN (Jentadueto)
linaGLIPtin (Tradjenta) AND metFORMIN (Glucophage)
linaGLIPtin-metFORMIN XR (JentaduetoXR)
linaGLIPtin (Tradjenta) AND metFORMIN XR (Glucophage XR)
Jentadueto medication guide
Jentadueto XR medication guide
metFORMIN -- hold for 48 hours post IV contrast media per radiologist, contraindications with CHF, renal disease, hepatic disease, and age. Pharmacist may order SCr.
Reviewed: February 28, 2012 and 23 August 2016 (Jentadueto XR)